A detailed history of Federated Hermes, Inc. transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 549,564 shares of ALDX stock, worth $2.63 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
549,564
Previous 531,221 3.45%
Holding current value
$2.63 Million
Previous $1.76 Million 68.49%
% of portfolio
0.01%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.19 - $6.32 $58,514 - $115,927
18,343 Added 3.45%
549,564 $2.96 Million
Q2 2024

Aug 08, 2024

BUY
$3.25 - $4.72 $1.73 Million - $2.51 Million
531,221 New
531,221 $1.76 Million
Q4 2023

Jan 31, 2024

SELL
$1.47 - $6.06 $30,605 - $126,169
-20,820 Reduced 98.85%
243 $0
Q2 2023

Aug 14, 2023

BUY
$7.11 - $11.89 $149,757 - $250,439
21,063 New
21,063 $176,000
Q2 2021

Aug 16, 2021

SELL
$10.44 - $14.85 $897 - $1,277
-86 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$6.53 - $14.42 $561 - $1,240
86 New
86 $1,000
Q4 2020

Feb 12, 2021

SELL
$6.31 - $8.13 $908 - $1,170
-144 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$4.0 - $7.53 $576 - $1,084
144 New
144 $1,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $279M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.